Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients
Clinical trial NCT02622932 · COMPLETED
Trial details
- NCT number
- NCT02622932
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2016-12-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.